170 related articles for article (PubMed ID: 35567427)
1. Alzheimer's disease associated AKAP9 I2558M mutation alters posttranslational modification and interactome of tau and cellular functions in CRISPR-edited human neuronal cells.
You Y; Hersh SW; Aslebagh R; Shaffer SA; Ikezu S; Mez J; Lunetta KL; Logue MW; Farrer LA; Ikezu T
Aging Cell; 2022 Jun; 21(6):e13617. PubMed ID: 35567427
[TBL] [Abstract][Full Text] [Related]
2. Tau Phosphorylation is Impacted by Rare AKAP9 Mutations Associated with Alzheimer Disease in African Americans.
Ikezu T; Chen C; DeLeo AM; Zeldich E; Fallin MD; Kanaan NM; Lunetta KL; Abraham CR; Logue MW; Farrer LA
J Neuroimmune Pharmacol; 2018 Jun; 13(2):254-264. PubMed ID: 29516269
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated tau interactome in the human Alzheimer's disease brain.
Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
[TBL] [Abstract][Full Text] [Related]
4. Tau interactome analyses in CRISPR-Cas9 engineered neuronal cells reveal ATPase-dependent binding of wild-type but not P301L Tau to non-muscle myosins.
Wang X; Williams D; Müller I; Lemieux M; Dukart R; Maia IBL; Wang H; Woerman AL; Schmitt-Ulms G
Sci Rep; 2019 Nov; 9(1):16238. PubMed ID: 31700063
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
6. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
[TBL] [Abstract][Full Text] [Related]
7. Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.
Jiang Y; Xu B; Chen J; Sui Y; Ren L; Li J; Zhang H; Guo L; Sun X
Med Sci Monit; 2018 Aug; 24():5635-5644. PubMed ID: 30102687
[TBL] [Abstract][Full Text] [Related]
8. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
9. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
Liu W; Zhao J; Lu G
Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
[TBL] [Abstract][Full Text] [Related]
10. Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans.
Logue MW; Schu M; Vardarajan BN; Farrell J; Bennett DA; Buxbaum JD; Byrd GS; Ertekin-Taner N; Evans D; Foroud T; Goate A; Graff-Radford NR; Kamboh MI; Kukull WA; Manly JJ; ;
Alzheimers Dement; 2014 Nov; 10(6):609-618.e11. PubMed ID: 25172201
[TBL] [Abstract][Full Text] [Related]
11. Comparative interactome mapping of Tau-protein in classical and rapidly progressive Alzheimer's disease identifies subtype-specific pathways.
Younas A; Younas N; Iqbal MJ; Ferrer I; Zerr I
Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12964. PubMed ID: 38374702
[TBL] [Abstract][Full Text] [Related]
12. Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease.
Ke YD; Dramiga J; Schütz U; Kril JJ; Ittner LM; Schröder H; Götz J
PLoS One; 2012; 7(4):e35678. PubMed ID: 22558197
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase.
Derkinderen P; Scales TM; Hanger DP; Leung KY; Byers HL; Ward MA; Lenz C; Price C; Bird IN; Perera T; Kellie S; Williamson R; Noble W; Van Etten RA; Leroy K; Brion JP; Reynolds CH; Anderton BH
J Neurosci; 2005 Jul; 25(28):6584-93. PubMed ID: 16014719
[TBL] [Abstract][Full Text] [Related]
14. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone-related neurosteroids differentially rescue bioenergetic deficits induced by amyloid-β or hyperphosphorylated tau protein.
Grimm A; Biliouris EE; Lang UE; Götz J; Mensah-Nyagan AG; Eckert A
Cell Mol Life Sci; 2016 Jan; 73(1):201-15. PubMed ID: 26198711
[TBL] [Abstract][Full Text] [Related]
16. Neuronal deficiency of p38α-MAPK ameliorates symptoms and pathology of APP or Tau-transgenic Alzheimer's mouse models.
Schnöder L; Gasparoni G; Nordström K; Schottek A; Tomic I; Christmann A; Schäfer KH; Menger MD; Walter J; Fassbender K; Liu Y
FASEB J; 2020 Jul; 34(7):9628-9649. PubMed ID: 32475008
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease pathological lesions activate the spleen tyrosine kinase.
Schweig JE; Yao H; Beaulieu-Abdelahad D; Ait-Ghezala G; Mouzon B; Crawford F; Mullan M; Paris D
Acta Neuropathol Commun; 2017 Sep; 5(1):69. PubMed ID: 28877763
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA 00507/miRNA-181c-5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease.
Yan Y; Yan H; Teng Y; Wang Q; Yang P; Zhang L; Cheng H; Fu S
J Gene Med; 2020 Dec; 22(12):e3268. PubMed ID: 32891070
[TBL] [Abstract][Full Text] [Related]
19. New age of neuroproteomics in Alzheimer's disease research.
Kovacech B; Zilka N; Novak M
Cell Mol Neurobiol; 2009 Sep; 29(6-7):799-805. PubMed ID: 19225878
[TBL] [Abstract][Full Text] [Related]
20. Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.
Bose A; Mouton-Liger F; Paquet C; Mazot P; Vigny M; Gray F; Hugon J
Brain Pathol; 2011 Mar; 21(2):189-200. PubMed ID: 21029237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
